Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2002
has subject area
- 0605 Microbiology (FoR)
- 1103 Clinical Sciences (FoR)
- 1108 Medical Microbiology (FoR)
- Administration, Oral (MeSH)
- Adult (MeSH)
- Aged (MeSH)
- Anti-Infective Agents (MeSH)
- Clinical Trials as Topic (MeSH)
- Community-Acquired Infections (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Drug Administration Schedule (MeSH)
- Female (MeSH)
- Fluoroquinolones (MeSH)
- Follow-Up Studies (MeSH)
- Gatifloxacin (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Microbiology (Science Metrix)
- Middle Aged (MeSH)
- Pneumonia, Bacterial (MeSH)
- Risk Assessment (MeSH)
- Safety (MeSH)
- Treatment Outcome (MeSH)
- United States (MeSH)